Benefits and harms of high-dose haemodiafiltration versus high-flux haemodialysis: the comparison of high-dose haemodiafiltration with high-flux haemodialysis (CONVINCE) trial protocol.
Average rating
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Star rating
Your vote was cast
Thank you for your feedback
Thank you for your feedback
Authors
Blankestijn, Peter JFischer, Kathrin I
Barth, Claudia
Cromm, Krister
Canaud, Bernard
Davenport, Andrew
Grobbee, Diederick E
Hegbrant, Jörgen
Roes, Kit C
Rose, Matthias
Strippoli, Giovanni Fm
Vernooij, Robin Wm
Woodward, Mark
de Wit, G Ardine
Bots, Michiel L
Type
ArticleLanguage
en
Metadata
Show full item recordTitle
Benefits and harms of high-dose haemodiafiltration versus high-flux haemodialysis: the comparison of high-dose haemodiafiltration with high-flux haemodialysis (CONVINCE) trial protocol.Published in
BMJ Open 2020; 10(2):e033228PMID
32029487ae974a485f413a2113503eed53cd6c53
10.1136/bmjopen-2019-033228
Scopus Count
Collections
Related articles
- The high-volume haemodiafiltration vs high-flux haemodialysis registry trial (H4RT): a multi-centre, unblinded, randomised, parallel-group, superiority study to compare the effectiveness and cost-effectiveness of high-volume haemodiafiltration and high-flux haemodialysis in people with kidney failure on maintenance dialysis using linkage to routine healthcare databases for outcomes.
- Authors: Caskey FJ, Procter S, MacNeill SJ, Wade J, Taylor J, Rooshenas L, Liu Y, Annaw A, Alloway K, Davenport A, Power A, Farrington K, Mitra S, Wheeler DC, Law K, Lewis-White H, Ben-Shlomo Y, Hollingworth W, Donovan J, Lane JA
- Issue date: 2022 Jun 27
- Haemodiafiltration, haemofiltration and haemodialysis for end-stage kidney disease.
- Authors: Nistor I, Palmer SC, Craig JC, Saglimbene V, Vecchio M, Covic A, Strippoli GF
- Issue date: 2015 May 20
- Effect of haemodiafiltration vs conventional haemodialysis on growth and cardiovascular outcomes in children - the HDF, heart and height (3H) study.
- Authors: Shroff R, Bayazit A, Stefanidis CJ, Askiti V, Azukaitis K, Canpolat N, Agbas A, Anarat A, Aoun B, Bakkaloglu S, Bhowruth D, Borzych-Dużałka D, Bulut IK, Büscher R, Dempster C, Duzova A, Habbig S, Hayes W, Hegde S, Krid S, Licht C, Litwin M, Mayes M, Mir S, Nemec R, Obrycki L, Paglialonga F, Picca S, Ranchin B, Samaille C, Shenoy M, Sinha M, Smith C, Spasojevic B, Vidal E, Vondrák K, Yilmaz A, Zaloszyc A, Fischbach M, Schaefer F, Schmitt CP
- Issue date: 2018 Aug 10
- Haemodiafiltration and mortality in end-stage kidney disease patients: a pooled individual participant data analysis from four randomized controlled trials.
- Authors: Peters SA, Bots ML, Canaud B, Davenport A, Grooteman MP, Kircelli F, Locatelli F, Maduell F, Morena M, Nubé MJ, Ok E, Torres F, Woodward M, Blankestijn PJ, HDF Pooling Project Investigators
- Issue date: 2016 Jun
- Haemodiafiltration, haemofiltration and haemodialysis for end-stage kidney disease.
- Authors: Rabindranath KS, Strippoli GF, Daly C, Roderick PJ, Wallace S, MacLeod AM
- Issue date: 2006 Oct 18